PED(PED)
PED
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $140M | $130M |
| Low | $130M | $127M |
| High | $151M | $132M |
| EBITDA Avg | $64M | $59M |
| Low | $59M | $57M |
| High | $68M | $60M |
| EBIT Avg | $7M | $7M |
| Low | $7M | $7M |
| High | $8M | $7M |
| Net Income Avg | $-2M | $4M |
| Low | $-3M | $2M |
| High | $-2M | $5M |
| EPS Avg | $-0.52 | $0.81 |
| Low | $-0.54 | $0.51 |
| High | $-0.49 | $1.11 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $33M | $30M | $32M | $32M | $32M | $34M |
| Low | $28M | $27M | $28M | $28M | $29M | $31M |
| High | $39M | $33M | $35M | $35M | $36M | $38M |
| EBITDA Avg | $15M | $14M | $14M | $14M | $15M | $15M |
| Low | $12M | $12M | $13M | $13M | $13M | $14M |
| High | $18M | $15M | $16M | $16M | $16M | $17M |
| EBIT Avg | $2M | $2M | $2M | $2M | $2M | $2M |
| Low | $1M | $1M | $1M | $1M | $1M | $2M |
| High | $2M | $2M | $2M | $2M | $2M | $2M |
| Net Income Avg | $1M | $547,102 | $1M | $1M | $2M | $2M |
| Low | $895,294 | $470,577 | $1M | $1M | $1M | $2M |
| High | $2M | $623,627 | $2M | $1M | $2M | $2M |
| EPS Avg | $0.18 | $0.07 | $0.18 | $0.17 | $0.20 | $0.27 |
| Low | $0.11 | $0.06 | $0.15 | $0.14 | $0.17 | $0.23 |
| High | $0.25 | $0.08 | $0.21 | $0.19 | $0.22 | $0.31 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |